138 related articles for article (PubMed ID: 21039823)
1. Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1.
Feldmann R; Schuierer G; Wessel A; Neveling N; Weglage J
Acta Paediatr; 2010 Nov; 99(11):1657-60. PubMed ID: 21039823
[TBL] [Abstract][Full Text] [Related]
2. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1.
Greenwood RS; Tupler LA; Whitt JK; Buu A; Dombeck CB; Harp AG; Payne ME; Eastwood JD; Krishnan KR; MacFall JR
Arch Neurol; 2005 Dec; 62(12):1904-8. PubMed ID: 16344348
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities.
Feldmann R; Denecke J; Grenzebach M; Schuierer G; Weglage J
Neurology; 2003 Dec; 61(12):1725-8. PubMed ID: 14694037
[TBL] [Abstract][Full Text] [Related]
4. T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.
Hyman SL; Gill DS; Shores EA; Steinberg A; North KN
J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1088-91. PubMed ID: 17299016
[TBL] [Abstract][Full Text] [Related]
5. MRI and nonverbal cognitive deficits in children with neurofibromatosis 1.
Bawden H; Dooley J; Buckley D; Camfield P; Gordon K; Riding M; Llewellyn G
J Clin Exp Neuropsychol; 1996 Dec; 18(6):784-92. PubMed ID: 9157104
[TBL] [Abstract][Full Text] [Related]
6. Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1.
Pride N; Payne JM; Webster R; Shores EA; Rae C; North KN
J Child Neurol; 2010 Jul; 25(7):834-41. PubMed ID: 20142468
[TBL] [Abstract][Full Text] [Related]
7. Examining the frontal subcortical brain vulnerability hypothesis in children with neurofibromatosis type 1: Are T2-weighted hyperintensities related to executive dysfunction?
Roy A; Barbarot S; Charbonnier V; Gayet-Delacroix M; Stalder JF; Roulin JL; Le Gall D
Neuropsychology; 2015 May; 29(3):473-84. PubMed ID: 25365565
[TBL] [Abstract][Full Text] [Related]
8. Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood.
Chabernaud C; Sirinelli D; Barbier C; Cottier JP; Sembely C; Giraudeau B; Deseille-Turlotte G; Lorette G; Barthez MA; Castelnau P
Dev Neuropsychol; 2009; 34(6):736-48. PubMed ID: 20183730
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 1 and cerebellar T2-hyperintensities: the relationship to cognitive functioning.
Piscitelli O; Digilio MC; Capolino R; Longo D; Di Ciommo V
Dev Med Child Neurol; 2012 Jan; 54(1):49-51. PubMed ID: 22107256
[No Abstract] [Full Text] [Related]
10. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.
Hyman SL; Gill DS; Shores EA; Steinberg A; Joy P; Gibikote SV; North KN
Neurology; 2003 Apr; 60(7):1139-45. PubMed ID: 12682321
[TBL] [Abstract][Full Text] [Related]
11. Cognitive control in adolescents with neurofibromatosis type 1.
Rowbotham I; Pit-ten Cate IM; Sonuga-Barke EJ; Huijbregts SC
Neuropsychology; 2009 Jan; 23(1):50-60. PubMed ID: 19210032
[TBL] [Abstract][Full Text] [Related]
12. [Encephalic lesions in neurofibromatosis: clinical manifestations and typical magnetic resonance findings].
Magnaldi S; White RM; Bryan RN
Radiol Med; 1990 Dec; 80(6):796-807. PubMed ID: 2126389
[TBL] [Abstract][Full Text] [Related]
13. [Cognitive impairment in adults with neurofibromatosis type 1].
Uttner I; Wahlländer-Danek U; Danek A
Fortschr Neurol Psychiatr; 2003 Mar; 71(3):157-62. PubMed ID: 12624853
[TBL] [Abstract][Full Text] [Related]
14. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
Hyman SL; Shores A; North KN
Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
[TBL] [Abstract][Full Text] [Related]
15. Cognitive profiles of neurofibromatosis type 1 patients with minor brain malformations.
Acosta MT; Walsh KS; Kardel PG; Kutteruf RE; Bhatt RR; Bouton TC; Vezina LG; Packer RJ
Pediatr Neurol; 2012 Apr; 46(4):231-4. PubMed ID: 22490768
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal assessment of cognition and T2-hyperintensities in NF1: an 18-year study.
Payne JM; Pickering T; Porter M; Oates EC; Walia N; Prelog K; North KN
Am J Med Genet A; 2014 Mar; 164A(3):661-5. PubMed ID: 24357578
[TBL] [Abstract][Full Text] [Related]
17. Neurological complications involving the central nervous system in neurofibromatosis type 1.
Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis.
Moore BD; Slopis JM; Schomer D; Jackson EF; Levy BM
Neurology; 1996 Jun; 46(6):1660-8. PubMed ID: 8649566
[TBL] [Abstract][Full Text] [Related]
19. Cognitive profile of neurofibromatosis type 1.
Levine TM; Materek A; Abel J; O'Donnell M; Cutting LE
Semin Pediatr Neurol; 2006 Mar; 13(1):8-20. PubMed ID: 16818171
[TBL] [Abstract][Full Text] [Related]
20. Social functioning in adults with neurofibromatosis type 1.
Pride NA; Crawford H; Payne JM; North KN
Res Dev Disabil; 2013 Oct; 34(10):3393-9. PubMed ID: 23911645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
